Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
D001593:Benzyl Compounds / Q000627:therapeutic use; D001786:Blood Glucose; D003374:Coumarins / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005905:Glyburide / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D007328:Insulin / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D011517:Prothrombin Time; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use
D001593:Benzyl Compounds; D001786:Blood Glucose; D003374:Coumarins; D007328:Insulin; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005905:Glyburide